These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14072915)

  • 1. UROKINASE IN OPHTHALMOLOGY.
    PIERSE D; LEGRICE H
    Lancet; 1963 Nov; 2(7318):1143-4. PubMed ID: 14072915
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF UROKINASE IN THE ANTERIOR CHAMBER OF THE EYE.
    PIERSE D; LEGRICE H
    J Clin Pathol; 1964 May; 17(3):362. PubMed ID: 14159484
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMPARATIVE STUDIES ON FIBRINOLYSIS ACTIVATED BY UROKINASE AND STREPTOKINASE IN HUMANS AND DOGS].
    BOROS M; BARANKAY A; SIMON L
    Med Pharmacol Exp Int J Exp Med; 1965; 12():184-9. PubMed ID: 14283800
    [No Abstract]   [Full Text] [Related]  

  • 4. SELECTIVE INHIBITION IN HUMAN PREGNANCY BLOOD OF UROKINASE INDUCED FIBRINOLYSIS.
    BRAKMAN P; ASTRUP T
    Scand J Clin Lab Invest; 1963; 15():603-9. PubMed ID: 14077014
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the effect of urokinase on the fibrinolytic activity of the blood].
    ANDREENKO GV; STRUKOVA SM
    Biokhimiia; 1962; 27():327-9. PubMed ID: 13861411
    [No Abstract]   [Full Text] [Related]  

  • 6. FIBRINOLYSIS AND HYPHEMA. THE EFFECT OF "UROKINASE" ON CLOTTED BLOOD IN THE ANTERIOR CHAMBER OF RABBIT EYES.
    HORVEN I; OPSAHL R
    Acta Ophthalmol (Copenh); 1964; 42():957-61. PubMed ID: 14247256
    [No Abstract]   [Full Text] [Related]  

  • 7. FIBRINOLYTIC AGENTS IN TREATMENT OF TOTAL HYPHEMA AND SECONDARY GLAUCOMA.
    ROBERTS RA
    Tex State J Med; 1965 Mar; 61():181-3. PubMed ID: 14266135
    [No Abstract]   [Full Text] [Related]  

  • 8. THE EUGLOBULIN METHOD FOR ESTIMATION OF FIBRINOLYTIC ACTIVITY IN UROKINASE-ACTIVATED PLASMA, AND THE INFLUENCE OF TRASYLOL.
    BLIX S
    Scand J Clin Lab Invest; 1964; 16():198-200. PubMed ID: 14161857
    [No Abstract]   [Full Text] [Related]  

  • 9. UROKINASE AND NON-ENZYMATIC FIBRINOLYTIC AGENTS.
    MCNICOL GP; DOUGLAS AS
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:34-6. PubMed ID: 14199707
    [No Abstract]   [Full Text] [Related]  

  • 10. THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.
    FLETCHER AP; ALKJAERSIG N; SHERRY S; GENTON E; HIRSH J; BACHMANN F
    J Lab Clin Med; 1965 May; 65():713-31. PubMed ID: 14281368
    [No Abstract]   [Full Text] [Related]  

  • 11. EVALUATION OF THE FIBRINOLYTIC STATE AFTER ADMINISTRATION OF UROKINASE.
    BAUMGARTEN W; PRIESTER LI; HERCZEG SA; WATSON LS
    Proc Soc Exp Biol Med; 1964 Apr; 115():1120-4. PubMed ID: 14166574
    [No Abstract]   [Full Text] [Related]  

  • 12. CURRENT DEVELOPMENTS IN OPHTHALMOLOGY. FIBRINOLYSIS IN RETINAL VASCULAR OCCLUSION.
    BLAKE J
    Proc R Soc Med; 1964 Jun; 57(6):493-4. PubMed ID: 14190868
    [No Abstract]   [Full Text] [Related]  

  • 13. FIBRINOLYTIC ACTIVITY OF TISSUE SECTIONS OF THE DOG KIDNEY.
    PROKOPOWICZ J; REJNIAK L; NIEWIAROWSKI S; WOROWSKI K
    Thromb Diath Haemorrh; 1964 Dec; 12():396-406. PubMed ID: 14254699
    [No Abstract]   [Full Text] [Related]  

  • 14. CLINICAL STUDIES WITH BUCCAL VARIDASE IN SOME EYE DISEASES.
    CHANDRA DB; GUPTA LC
    Am J Ophthalmol; 1964 Nov; 58():828-35. PubMed ID: 14220498
    [No Abstract]   [Full Text] [Related]  

  • 15. FIBRINOLYSIS.
    ADAMIS D
    Conn Med; 1964 Sep; 28():662-7. PubMed ID: 14201318
    [No Abstract]   [Full Text] [Related]  

  • 16. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 17. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 18. THE STUDY OF STREPTOKINASE- AND UROKINASE-ACTIVATED PLASMINOGEN.
    RYBAK M; PETAKOVA M; SIMONIANOVA E
    Clin Chim Acta; 1964 Oct; 10():330-6. PubMed ID: 14219577
    [No Abstract]   [Full Text] [Related]  

  • 19. [TRYPSIN-CHYMOTRYPSIN IN THE VASCULAR OCCLUSIVE PROCESSES].
    MOSSO HE; PERGOLA F; MARCEILLAC E
    Prensa Med Argent; 1963 Apr; 50():1081-4. PubMed ID: 14089189
    [No Abstract]   [Full Text] [Related]  

  • 20. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.